Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Adynxx Inc ADYX

Healthcare Biotechnology
Adynxx, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to market disease-modifying products to address unmet needs in the treatment of pain and inflammation. The Company has leveraged its AYX platform of proprietary transcription factor decoys to identify and develop... see more

Recent & Breaking News (GREY:ADYX)

Alliqua BioMedical, Inc. to Present New Data at the Spring 2017 Symposium on Advanced Wound Care

GlobeNewswire April 5, 2017

Alliqua BioMedical, Inc. Announces Closing of Approximately $3.8 Million Public Offering

GlobeNewswire April 3, 2017

Alliqua BioMedical, Inc. Announces Pricing of Public Offering of Common Stock

GlobeNewswire March 29, 2017

Alliqua BioMedical, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire March 28, 2017

Alliqua BioMedical, Inc. Announces the Publication of a Peer-reviewed Study Examining the Use of MIST Therapy for Deep Tissue Pressure Injuries

GlobeNewswire March 20, 2017

Alliqua BioMedical, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results

GlobeNewswire March 7, 2017

Alliqua BioMedical, Inc. to Present at the Cowen and Company 37th Annual Health Care Conference on March 8th

GlobeNewswire March 2, 2017

Alliqua BioMedical, Inc. to Announce Fourth Quarter and Fiscal Year 2016 Results on March 7th

GlobeNewswire March 1, 2017

Alliqua BioMedical, Inc. Announces the Closing of Approximately $2.8 Million Private Placement

GlobeNewswire February 28, 2017

Alliqua BioMedical, Inc. Announces Termination of its Agreement to Acquire Soluble Systems, LLC

GlobeNewswire February 28, 2017

Alliqua BioMedical, Inc. Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results

GlobeNewswire November 4, 2016

Alliqua BioMedical, Inc. Announces Expansion of Medicare Reimbursement Coverage for MIST Therapy®

GlobeNewswire October 10, 2016

Alliqua BioMedical, Inc. to Acquire Soluble Systems, LLC

GlobeNewswire October 5, 2016

Alliqua BioMedical, Inc. Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th

GlobeNewswire October 5, 2016

Alliqua BioMedical, Inc. Expands Regenerative Medicine Portfolio with the Commercial Introduction of Interfyl Connective Tissue Matrix

GlobeNewswire September 19, 2016

Alliqua BioMedical, Inc. Reports Second Quarter and Six Months Fiscal Year 2016 Financial Results

GlobeNewswire August 9, 2016

GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress

GlobeNewswire August 9, 2016

Alliqua BioMedical And BSN medical Reach Distribution Rights Agreement For Sorbion Dressing Products

Benzinga.com  July 7, 2016

Alliqua BioMedical, Inc. and BSN medical, Inc. Announce Definitive Agreement on Distribution Rights for Sorbion Dressing Products in the U.S., Canada and Latin America; Alliqua Updates Fiscal Year 2016 Outlook

GlobeNewswire July 7, 2016

Alliqua BioMedical, Inc. Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for August 9th

GlobeNewswire July 7, 2016